Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts
Carolina Dagli-Hernandez, Yitian Zhou, Volker M. Lauschke, et al.
Pharmacological Reports (2021) Vol. 74, Iss. 1, pp. 47-66
Closed Access | Times Cited: 17

Showing 17 citing articles:

Statins—Their Role in Bone Tissue Metabolism and Local Applications with Different Carriers
Marcin Mateusz Granat, Joanna Eifler-Zydel, Joanna Kolmas
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2378-2378
Open Access | Times Cited: 10
The natural compound sinometumine E derived from Corydalis decumbens promotes angiogenesis by regulating HIF-1/ VEGF pathway in vivo and in vitro
Yuqi Wang, Shuhui Wang, Yanhang Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117113-117113
Open Access | Times Cited: 6
Epidrugs in the clinical management of atherosclerosis: Mechanisms, challenges and promises
Sushma Panduga, Sampara Vasishta, Ramamoorthy Subramani, et al.
European Journal of Pharmacology (2024) Vol. 980, pp. 176827-176827
Open Access | Times Cited: 4
Personalized Statin Therapy: Targeting Metabolic Processes to Modulate the Therapeutic and Adverse Effects of Statins
Zhuangqi Shi, Shuxin Han
Heliyon (2025) Vol. 11, Iss. 1, pp. e41629-e41629
Closed Access
Study of the antihyperlipidemic effect of Ammodaucus leucotrichus essential oil in rats
Ayoub Amssayef, Bouchra Soulaimani, Imane Abbad, et al.
Comparative Clinical Pathology (2025)
Closed Access
Association between CYP3A4/CYP3A5 genetic polymorphisms and treatment outcomes of atorvastatin worldwide: is there enough research on the Egyptian population?
Mohammed G. Maslub, Mahasen A. Radwan, Nur Aizati Athirah Daud, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 5
Physiologically based pharmacokinetic combined JAK2 occupancy modelling to simulate PK and PD of baricitinib with kidney transporter inhibitors and in patients with hepatic/renal impairment
Zhongjian Wang, Wei Liu, Xueyan Li, et al.
Regulatory Toxicology and Pharmacology (2022) Vol. 133, pp. 105210-105210
Open Access | Times Cited: 7
Genetic Variant ABCC1 rs45511401 Is Associated with Increased Response to Statins in Patients with Familial Hypercholesterolemia
Carolina Dagli-Hernandez, Jéssica Bassani Borges, Elisangela da Silva Rodrigues Marçal, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 944-944
Open Access | Times Cited: 6
Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia
Natchaya Vanwong, Sayanit Tipnoppanon, Chalitpon Na Nakorn, et al.
Pharmacogenomics and Personalized Medicine (2022) Vol. Volume 15, pp. 119-130
Open Access | Times Cited: 6
Predicted deleterious variants in ABCA1, LPL, LPA and KIF6 are associated with statin response and adverse events in patients with familial hypercholesterolemia and disturb protein structure and stability
Carolina Dagli-Hernandez, Gláucio Monteiro Ferreira, Renata Caroline Costa de Freitas, et al.
Pharmacogenetics and Genomics (2024) Vol. 34, Iss. 4, pp. 91-104
Closed Access
Associations Between the Polymorphisms in the Coding Sequence of SLCO1B1 and Blood Lipid Levels Before and After Treatment by Atorvastatin in the Chinese Han Adults with Dyslipidemia
Chao Chen, Yan Tian, Jia Fu, et al.
Pharmacogenomics and Personalized Medicine (2024) Vol. Volume 17, pp. 551-561
Open Access
A mini-review to the common adverse-effects of statins
Hamid Nasri
Journal of Renal Endocrinology (2022) Vol. 8, pp. e25071-e25071
Open Access | Times Cited: 2
SLCO1B1 and CYP3A4 allelic variants associated with pharmacokinetic interactions and adverse reactions induced by simvastatin and atorvastatin used in Peru: Clinical implications
Ángel T. Alvarado, Ana María Muñoz, Roberto O. Ybañez‐Julca, et al.
Journal of Pharmacy & Pharmacognosy Research (2023) Vol. 11, Iss. 6, pp. 934-952
Open Access
Association of high LDL concentrations with erectile dysfunction from a Mendelian randomization study
Quan Zhu, Yao Tan, Xuyan Zou, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access
Apport de la pharmacogénétique dans le domaine cardio-vasculaire, l’exemple des statines
Houwaida Abbes, Sana Boujaafar, Marwa Ajmi, et al.
Actualités Pharmaceutiques (2022) Vol. 61, Iss. 616, pp. 31-36
Closed Access
Pharmacogenomic analysis in patients with familial hypercholesterolemia
Carolina Dagli-Hernandez
(2022)
Open Access
Adenosine Triphosphate Exerts Cardioprotective Effect on High-Dose Atorvastatin-Induced Heart Damage in Rats
Reşit Çoşkun
Erzincan Üniversitesi Fen Bilimleri Enstitüsü Dergisi (2022) Vol. 15, Iss. 2, pp. 533-543
Open Access
Page 1

Scroll to top